Article
Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
Clinical pharmacology and therapeutics - 1 Sept 2002
Pawlik Andrzej, Ostanek Lidia, Brzosko Iwona, Gawroska-Szklarz Barbara, Brzosko Marek, Dabrowska-Zamojcin Ewa
Abstract excerpt
OBJECTIVES: Acetylation polymorphism can alter therapeutic responses and toxicity to certain xenobiotics and may also be a factor that influences a patient's susceptibility to certain diseases. We investigated whether patients with rheumatoid arthritis (RA) differed from healthy individuals with regard to genotype of the polymorphic enzyme N-acetyltransferase 2 (NAT2). METHODS: NAT2 polymorphism was compared in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
